Osteoporosis Is Associated with an Increased Risk of Colorectal Adenoma and High-Risk Adenoma: A Retrospective, Multicenter, Cross-Sectional, Case-Control Study
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: The protective effects of vitamin D and calcium on colorectal neoplasms are known. Bone mineral density (BMD) may be a reliable biomarker that reflects the long-term anticancer effect of vitamin D and calcium. This study aimed to evaluate the association between BMD and colorectal adenomas including high-risk adenoma. Methods: A multicenter, cross-sectional, case-control study was conducted among participants with average risk of colorectal cancer who underwent BMD and screening colonoscopy between 2015 and 2019. The main outcome was the detection of colorectal neoplasms. The variable under consideration was low BMD (osteopenia/osteoporosis). The logistic regression model included baseline demographics, components of metabolic syndrome, fatty liver disease status, and aspirin and multivitamin use. Results: A total of 2,109 subjects were enrolled. The mean age was 52.1±10.8 years and 42.6% were male. The adenoma detection rate was 43%. Colorectal adenoma and high-risk adenoma were both more prevalent in subjects with low BMD than those with normal BMD (48.2% vs 38.8% and 12.1% vs 9.1%). In the univariate analysis, old age, male sex, smoking, metabolic components, fatty liver, and osteoporosis were significantly associated with the risk of adenoma and high-risk adenoma. In the multivariate analysis, osteoporosis was independently associated with risk of colorectal adenoma (odds ratio [OR], 1.65; 95% confidence interval [CI], 1.11 to 2.46; p=0.014) and high-risk adenoma (OR, 1.94; 95% CI, 1.14 to 3.29; p=0.014). Conclusions: Osteoporosis is an independent risk factor of colorectal adenoma and high-risk adenoma.
Abstract
Background/Aims: The protective effects of vitamin D and calcium on colorectal neoplasms are known. Bone mineral density (BMD) may be a reliable biomarker that reflects the long-term anticancer effect of vitamin D and calcium. This study aimed to evaluate the association between BMD and colorectal adenomas including high-risk adenoma. Methods: A multicenter, cross-sectional, case-control study was conducted among participants with average risk of colorectal cancer who underwent BMD and screening colonoscopy between 2015 and 2019. The main outcome was the detection of colorectal neoplasms. The variable under consideration was low BMD (osteopenia/osteoporosis). The logistic regression model included baseline demographics, components of metabolic syndrome, fatty liver disease status, and aspirin and multivitamin use. Results: A total of 2,109 subjects were enrolled. The mean age was 52.1±10.8 years and 42.6% were male. The adenoma detection rate was 43%. Colorectal adenoma and high-risk adenoma were both more prevalent in subjects with low BMD than those with normal BMD (48.2% vs 38.8% and 12.1% vs 9.1%). In the univariate analysis, old age, male sex, smoking, metabolic components, fatty liver, and osteoporosis were significantly associated with the risk of adenoma and high-risk adenoma. In the multivariate analysis, osteoporosis was independently associated with risk of colorectal adenoma (odds ratio [OR], 1.65; 95% confidence interval [CI], 1.11 to 2.46; p=0.014) and high-risk adenoma (OR, 1.94; 95% CI, 1.14 to 3.29; p=0.014). Conclusions: Osteoporosis is an independent risk factor of colorectal adenoma and high-risk adenoma.
참고문헌 (32)
- Hyung-Hoon Oh, "Novel biomarkers for the diagnosis and prognosis of colorectal cancer", Intestinal research, 18(2), pp.168~183 (2020), 대한장연구학회[DOI]
- Byers SW, "Mechanism of action of vitamin D and the vitamin D receptor in colorectal cancer prevention and treatment", Rev Endocr Metab Disord, 13, pp.31~38 (2012)
- Chung M, "Vitamin D with or without calcium supplementation for prevention of cancer and fractures : an updated meta-analysis for the U. S. Preventive Services Task Force", Ann Intern Med, 155, pp.827~838 (2011)
- Ganry O, "Bone mass density, subsequent risk of colon cancer and survival in postmenopausal women", Eur J Epidemiol, 23, pp.467~473 (2008)
- Wactawski-Wende J, "Calcium plus vitamin D supplementation and the risk of colorectal cancer", N Engl J Med, 354, pp.684~696 (2006)
- 전상민, "Exploring vitamin D metabolism and function in cancer", Experimental and Molecular Medicine, 50, pp.1~14 (2018), 생화학분자생물학회
- Song M, "Nutrients, foods, and colorectal cancer prevention", Gastroenterology, 148, pp.1244~1260 (2015)
- Mondul AM, "Vitamin D and cancer risk and mortality : state of the science, gaps, and challenges", Epidemiol Rev, 39, pp.28~48 (2017)
- Bae JM, "Molecular subtypes of colorectal cancer and their clinicopathologic features, with an emphasis on the serrated neoplasia pathway", Arch Pathol Lab Med, 140, pp.406~412 (2016)
- Baron JA, "A trial of calcium and vitamin D for the prevention of colorectal adenomas", N Engl J Med, 373, pp.1519~1530 (2015)
- Shaukat A, "Role of supplemental calcium in the recurrence of colorectal adenomas : a metaanalysis of randomized controlled trials", Am J Gastroenterol, 100, pp.390~394 (2005)
- Sy AM, "Association between serum vitamin D levels and colonic carcinomatous polyps", J Gastrointest Cancer, 44, pp.481~485 (2013)
- Nelson RL, "Bone mineral density and the subsequent risk of cancer in the NHANES I followup cohort", BMC Cancer, 2, pp.22~ (2002)
- Lim JU, "Osteoporosis is associated with the risk of colorectal adenoma in women", Dis Colon Rectum, 56, pp.169~174 (2013)
- Nock NL, "Higher bone mineral density is associated with a decreased risk of colorectal adenomas", Int J Cancer, 129, pp.956~964 (2011)
- Gowda S, "Low bone mineral density linked to colorectal adenomas : a cross-sectional study of a racially diverse population", J Gastrointest Oncol, 6, pp.165~171 (2015)
- Gupta S, "Spotlight : US Multi-Society Task Force on colorectal cancer recommendations for follow-up after colonoscopy and polypectomy", Gastroenterology, 158, pp.1154~ (2020)
- "Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO Study Group", World Health Organ Tech Rep Ser, 843, pp.1~129 (1994)
- Alberti KG, "Harmonizing the metabolic syndrome : a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute;American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity", Circulation, 120, pp.1640~1645 (2009)
- Jacobs ET, "Association between circulating concentrations of 25(OH)D and colorectal adenoma : a pooled analysis", Int J Cancer, 133, pp.2980~2988 (2013)
- Barry EL, "Vitamin D receptor genotype, vitamin D3 supplementation, and risk of colorectal adenomas : a randomized clinical trial", JAMA Oncol, 3, pp.628~635 (2017)
- Brot C, "Relationships between bone mineral density, serum vitamin D metabolites and calcium : phosphorus intake in healthy perimenopausal women", J Intern Med, 245, pp.509~516 (1999)
- Man PW, "Vitamin D status and bone mineral density in the Chinese population : a review", Arch Osteoporos, 11, pp.14~ (2016)
- Ashmore JH, "No association between vitamin D Intake, VDR polymorphisms, and colorectal cancer in a populationbased case-control study", Cancer Epidemiol Biomarkers Prev, 24, pp.1635~1637 (2015)
- Kampman E, "Calcium, vitamin D, sunshine exposure, dairy products and colon cancer risk(United States)", Cancer Causes Control, 11, pp.459~466 (2000)
- Robsahm TE, "Vitamin D3from sunlight may improve the prognosis of breast-, colon-and prostate cancer(Norway)", Cancer Causes Control, 15, pp.149~158 (2004)
- Freedman DM, "Prospective study of serum vitamin D and cancer mortality in the United States", J Natl Cancer Inst, 99, pp.1594~1602 (2007)
- Ng K, "Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer", J Clin Oncol, 26, pp.2984~2991 (2008)
- Black DM, "Postmenopausal osteoporosis", N Engl J Med, 374, pp.2096~2097 (2016)
- Amitay EL, "Postmenopausal hormone replacement therapy and colorectal cancer risk by molecular subtypes and pathways", Int J Cancer, 147, pp.1018~1026 (2020)
- Thosani N, "Reduced risk of colorectal cancer with use of oral bisphosphonates : a systematic review and meta-analysis", J Clin Oncol, 31, pp.623~630 (2013)
- Newmark HL, "and colon cancer", Cancer Res, 52(7 Suppl), pp.2067s~2070s (1992)